Ely, United Kingdom

Frances Anne Penrose

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Frances Anne Penrose: Innovator in Drug Delivery Technology

Introduction

Frances Anne Penrose is a notable inventor based in Ely, GB. She has made significant contributions to the field of drug delivery technology, particularly with her innovative designs that enhance the efficiency and safety of drug administration.

Latest Patents

Frances holds a patent for a drug injection device. This device features a housing with a cartridge that contains a predetermined drug volume. It includes a dose setting mechanism for accurately setting a drug dose and a dose delivery mechanism for administering the drug. The design incorporates a last dose setting device that prevents the setting of a drug dose greater than the remaining drug volume in the cartridge. This innovative approach ensures that patients receive the correct dosage while minimizing the risk of errors.

Career Highlights

Frances has dedicated her career to advancing medical technology. Her work at Stevanato Group S.p.a. has positioned her as a leader in the development of drug delivery systems. With her expertise, she has contributed to the creation of devices that improve patient outcomes and streamline the drug administration process.

Collaborations

Frances has collaborated with talented individuals such as Philip Jake Cohen and Conor Devine. These partnerships have fostered an environment of innovation and creativity, leading to the development of cutting-edge technologies in the medical field.

Conclusion

Frances Anne Penrose is a pioneering inventor whose work in drug delivery technology has made a significant impact on healthcare. Her innovative designs and collaborative spirit continue to drive advancements in the industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…